News from NORD

Largest-Ever Study of Pemphigus and Pemphigoid Launched


 

A natural history registry that will provide a complete picture of each patient’s experience with pemphigus and pemphigoid has been launched by the International Pemphigus and Pemphigoid Foundation with NORD. This study will be open to patient worldwide to advance understanding and treatments for these rare conditions. The registry will be maintained on a platform developed by NORD in line with its mission to seek treatments or cures for all rare diseases. The project is supported by a cooperative agreement between NORD and the US Food and Drug Administration (FDA).

Recommended Reading

NORD Awards Grants for Rare Disease Research
Clinician Reviews
NORD Publishes Basic Principles for Health Coverage Reform
Clinician Reviews
NORD Submits Letter to Congress on Pre-Existing Conditions
Clinician Reviews
NORD Unveils “Do Your Share for Rare” Year-Long Awareness Campaign
Clinician Reviews
Tickets Now On Sale for NORD’s 2017 Rare Impact Awards
Clinician Reviews
NORD Announces Recipients of 2017 Rare Impact Awards
Clinician Reviews
NORD and Neurology Reviews Publish Special Report
Clinician Reviews
Save the Date for the 2017 NORD Summit
Clinician Reviews
Film Festival Devoted to Rare Diseases Scheduled for October
Clinician Reviews
Applications Are Being Accepted for Free Family Rare Disease Summer Camp
Clinician Reviews